Ranbaxy Wins FDA Approval To Sell Generic Diovan
Ranbaxy Laboratories Ltd. announced Friday that it had received permission from the U.S. Food and Drug Administration for a subsidiary to begin selling a generic version of the widely prescribed blood...To view the full article, register now.
Already a subscriber? Click here to view full article